Pre clinical Science Bldg LR3 — Washington D.C., District of Columbia

Pre clinical Science Bldg LR3 is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Pre clinical Science Bldg LR3 has participated in 1 clinical trials.

Therapeutic areas: Locally Recurrent Breast Cancer, Metastatic Breast Cancer.

Sponsors: Nektar Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pre clinical Science Bldg LR3?

Pre clinical Science Bldg LR3 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pre clinical Science Bldg LR3 conducted?

Pre clinical Science Bldg LR3 has 1 clinical trials on record. Their work covers Locally Recurrent Breast Cancer, Metastatic Breast Cancer.

Is Pre clinical Science Bldg LR3 accredited by Crixeo Health?

Pre clinical Science Bldg LR3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pre clinical Science Bldg LR3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.